Since 1993, the AACR has awarded more than $542 million in grants to fund meritorious research projects across the spectrum of cancer science, including basic, translational, and clinical research. See how the AACR grants program has contributed to the AACR's mission.
The AACR and Bayer have been collaborating since 2015 to support the most promising and innovative cancer-focused research through different grant mechanisms. This partnership has yielded significant fruits, as indicated in this article.
In 2003, Patrick Ma, MD, received the AACR-AstraZeneca-Cancer Research and Prevention Foundation fellowship and used it to study c-Met mutations in lung cancer and the therapeutic potential of targeting c-Met. He's now leader of the multidisciplinary thoracic oncology disease team at the Penn State Cancer Institute. Read how the AACR fellowship helped launch his career.
A post-doctoral fellow at the Olivia Newton-John Cancer Research Institute, Australia, Ashleigh Poh, PhD, received one of the gastric cancer research fellowships given in 2018. She set out to investigate the role of hematopoietic Cell Kinase (HCK) in gastric cancer. Dr. Poh shared how her AACR fellowship made an impact on her research and career.
October is breast cancer awareness month. Researchers supported by the partnership between the AACR and the Breast Cancer Research Foundation have made progress in the understanding and treatment of breast cancer on multiple fronts.
The Breast Cancer Research Foundation-AACR Career Development Awards for Translational Breast Cancer Research support innovative breast cancer-focused research. 2018 recipient Camila dos Santos, PhD, shared how her career development award made an impact on her research and career.
October is breast cancer awareness month. Researchers supported by the partnership between the AACR and the Triple-Negative Breast Cancer Foundation have made progress against triple-negative breast cancer on multiple fronts.
2020 AACR-AstraZeneca Immuno-Oncology Fellow, Maria Casanova-Acebes, PhD, now current head of the Cancer Immunity Group at the Spanish National Cancer Research Centre (CNIO), reported in Nature their findings on how tissue-resident macrophages may influence lung cancer development.
The AACR-Bayer START grant gives early career investigators the unique opportunity to gain experience not only in academic but also in industry settings. Mark Labrecque, PhD, speaks on the impact of this grant on his career and research.
Protein tyrosine phosphatase non-receptor type 22 (PTPN22) has been primarily studied in the context of autoimmune diseases. 2019 AACR-InCyte Immuno-oncology Fellow Won Jin Ho, MD, showed how PTPN22 inhibition retards tumor growth in a T-cell- and macrophage-dependent manner.
In recognition of the need to advance the science of lung cancer prevention and interception, the 2019 AACR-J&J Lung Cancer Innovation Science Grants program awarded grants to two multi-institutional teams whose multifaceted projects seek to understand how an individual’s genetics may affect smoking-related behaviors and quit attempts, as well as to develop clinically actionable smoking cessation strategies that will improve patient outcomes.